Open Access

[Retracted] MicroRNA‑30e inhibits adhesion, migration, invasion and cell cycle progression of prostate cancer cells via inhibition of the activation of the MAPK signaling pathway by downregulating CHRM3

  • Authors:
    • Xin-Min Zheng
    • Peng Zhang
    • Man-Hua Liu
    • Ping Chen
    • Wei-Bing Zhang
  • View Affiliations

  • Published online on: July 15, 2024     https://doi.org/10.3892/ijo.2024.5670
  • Article Number: 82
  • Copyright : © Zheng et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Article

Related Articles

Journal Cover

September-2024
Volume 65 Issue 3

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Zheng X, Zhang P, Liu M, Chen P and Zhang W: [Retracted] MicroRNA‑30e inhibits adhesion, migration, invasion and cell cycle progression of prostate cancer cells via inhibition of the activation of the MAPK signaling pathway by downregulating CHRM3. Int J Oncol 65: 82, 2024.
APA
Zheng, X., Zhang, P., Liu, M., Chen, P., & Zhang, W. (2024). [Retracted] MicroRNA‑30e inhibits adhesion, migration, invasion and cell cycle progression of prostate cancer cells via inhibition of the activation of the MAPK signaling pathway by downregulating CHRM3. International Journal of Oncology, 65, 82. https://doi.org/10.3892/ijo.2024.5670
MLA
Zheng, X., Zhang, P., Liu, M., Chen, P., Zhang, W."[Retracted] MicroRNA‑30e inhibits adhesion, migration, invasion and cell cycle progression of prostate cancer cells via inhibition of the activation of the MAPK signaling pathway by downregulating CHRM3". International Journal of Oncology 65.3 (2024): 82.
Chicago
Zheng, X., Zhang, P., Liu, M., Chen, P., Zhang, W."[Retracted] MicroRNA‑30e inhibits adhesion, migration, invasion and cell cycle progression of prostate cancer cells via inhibition of the activation of the MAPK signaling pathway by downregulating CHRM3". International Journal of Oncology 65, no. 3 (2024): 82. https://doi.org/10.3892/ijo.2024.5670